| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $11.1M | $18.2M | $65.9M |
| YoY Revenue Growth % | -38.7% | -72.4% | — |
| Gross Profit | $5.3M | $7.4M | — |
| Gross Margin % | 47.7% | 40.7% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$13.1M | -$27.2M | -$12.3M |
| Operating Margin % | -80.0% | -80.0% | -18.7% |
| Net Income (GAAP) | -$17.5M | -$26.8M | -$53.1M |
| EBITDA (Normalized) | -$13.1M | -$27.2M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$23.0M | $21.2M | $33.2M |
| Capital Expenditures (CapEx) | $79.0K | $47.0K | — |
| Free Cash Flow (FCF) | -$23.1M | $21.1M | $33.2M |
| FCF Margin % | -80.0% | 80.0% | 50.3% |
| Return on Invested Capital (ROIC %) | -39.8% | -45.0% | — |
| Cash & Short-Term Equivalents | $534.0K | $2.6M | — |
| Total Debt (Short + Long Term) | $0 | $17.4M | — |
| Total Stockholders' Equity | $26.6M | -$587.0K | — |